Geriatrics
News
DXA screening: You’re doing it wrong
DXA is underused in women who meet the U.S. Preventive Services Task Force criteria for osteoporosis screening and overused in women who do not....
Conference Coverage
PAS: Prophylactic indomethacin not associated with lower risk of BPD, death in preterm infants
Prophylactic indomethacin offers no benefit to premature infants in terms of reducing the risk of BPD or death.
Conference Coverage
SAEM: High-risk subtypes of delirium are easily missed
Key clinical point: Delirium and a normal state of arousal was associated with a higher 6 month mortality rate than was delirium and either...
Conference Coverage
DDW: Recurrent C. difficile infections take heavy toll on IBD patients
Inflammatory bowel disease patients are at one-third higher risk for recurrent Clostridium difficile infections than is the general population.
News
Statins, fibrates lower stroke risk in elderly
Key clinical point: Statin and fibrate therapies significantly decreased stroke risk in a large cohort of elderly people. Major finding: The risk...
Conference Coverage
ATS: Aclidinium/formoterol bests salmeterol/fluticasone for bronchodilation in COPD
Key clinical point: In patients with COPD, aclidinium/formoterol demonstrated greater bronchodilation, compared with salmeterol/fluticasone. Major...
News
Prevalence of amyloid pathology differs across dementia type and age
The prevalence of amyloid pathology on PET imaging varies according to what type of dementia the patient has, patient age, and apolipoprotein E...
Conference Coverage
ATS: High-dose nitric oxide looks promising for infants with bronchiolitis
Key clinical point: Intermittent high-dose inhaled nitric oxide was safe and shows signals of efficacy in infants with acute bronchiolitis. Major...
Conference Coverage
VIDEO: MRI-compatible ICDs represent important advance
Conference Coverage
AUA: Very low-risk prostate cancers cause few deaths over 15 years
NEW ORLEANS – Long-term active surveillance seems to be a safe and effective way to avoid overtreatment in men with low- and very low-risk...
Conference Coverage
ATS: Nintedanib found effective for IPF up to 76 weeks
The use of nintedanib 150 mg twice daily slowed disease progression in patients with idiopathic pulmonary fibrosis up to 76 weeks of treatment,...